High-stakes Novo Nordisk Alzheimer's studies could yield answers on GLP-1 benefit

reuters.com/business/healthcare-pharmaceuticals/high-stakes-novo-nordisk-alzheimers-studies-could-yield-answers-glp-1-benefit-2025-11-20

This story appeared on reuters.com, 2025-11-20 11:08:17.351000.
The Entire Business World on a Single Page. Free to Use →